In patients with nonischemic cardiomyopathy, women had lower rates of ventricular arrhythmias and death than men, especially if they had a cardiac resynchronization therapy defibrillator, according to the results of the BIO-LIBRA study. Results from the second interim analysis of BIO-LIBRA, which was designed to include at least 40% women, who are traditionally underrepresented in implantable